Effectiveness of targeted intervention and maintenance pharmacotherapy in conjunction with family intervention in schizophrenia
Abstract
A sample of 85 patients with schizophrenia, of whom 34 later dropped out, received randomised treatment. There were no significant differences between treatment-takers and drop-outs in the variables assessed. Patients received either standard-dose maintenance neuroleptic treatment or targeted maintenance pharmacotherapy and all patients received behavioural family therapy. Measures of psychopathology, social adjustment, side-effects, family burden, and expressed emotion were assessed at baseline and then periodically over an 18-month period. The study was designed to compare the two alternative pharmacological maintenance approaches, each of them supported by psychosocial intervention. Any evaluation of the impact of behavioural family treatment on relapse rates and other outcome criteria is exclusively descriptive. A significantly higher rate of relapse was observed at 18 months in patients randomised to targeted treatment compared to those randomised to standard-dose treatment (35% vs 4%). Although patients assigned to the targeted maintenance group received significantly lower mean doses of neuroleptics, there were no significant differences between the two groups with regard to side-effects, global measures of social function, and overall psychopathology. Family burden was higher in the targeted-treatment group at six months, but did not differ at the one-year and eighteen-month time points. However, both groups improved significantly from baseline to 12 or 18 months in a…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Psychoeducation interventions have reduced levels of expressed emotion, stress and burden in relatives.
“se ha visto que dichas intervenciones han reducido los niveles de emoción expresada (e.g., Miklowitz, 2007; Wiedemann et al., 2001), de estrés y carga”
From Intervención psicológica grupal, basada en la aceptación y el entrenamiento en comunicación, con familiares de personas con trastorno mental grave (2015) · cites this paper as Wiedemann et al., 2001
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090 · see citing works
(1976) · Medical Entomology and Zoology · Cited by 8,899 · see citing works
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,946 · see citing works
The Global Assessment Scale: A Procedure for Measuring Overall Severity of Psychiatric Disturbance
Endicott, J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770060086012 · Cited by 4,982 · see citing works
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
Simpson, G. M., B., M., B., G., Angus, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,265 · see citing works
Assessment of social adjustment by patient self report.
Weissman, M. M. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770090101010 · Cited by 1,782 · see citing works
The Influence of Family and Social Factors on the Course of Psychiatric Illness
Vaughn, C. E., & Leff, J. (1976) · The British Journal of Psychiatry · doi:10.1192/bjp.129.2.125 · Cited by 1,665 · see citing works
Expressed Emotion and Psychiatric Relapse: A Meta-analysis
Butzlaff, R. L., & Hooley, J. M. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.6.547 · Cited by 1,310 · cited 1× · see citing works
“…validity of the EE rating has been investigated in 27 studies world-wide resulting in a median relapse rate nine months after discharge of 48 % for patients living with an high EE relative in contrast to 21 % for patients living in a low EE family (Butzlaff and Hooley, 1998; Kavanagh, 1992).”
ResultLehman, A. F., Steinwachs, D. M., & The Co-Investigators of the PORT Project (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033302 · Cited by 910 · see citing works
A Controlled Trial of Social Intervention in the Families of Schizophrenic Patients
Leff, J., Kuipers, L., Berkowitz, R., Eberlein-Vries, R., & Sturgeon, D. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.141.2.121 · Cited by 869 · see citing works
Family Management in the Prevention of Exacerbations of Schizophrenia
Falloon, I. R. H., Boyd, J. L., McGill, C. W., Razani, J., Moss, H. B., & Gilderman, A. M. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206173062401 · Cited by 684 · see citing works
The Prediction of Outcome in Schizophrenia
Strauss, J. S. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760130021003 · Cited by 645 · see citing works
Recent Developments in Expressed Emotion and Schizophrenia
Kavanagh, D. J. (1992) · The British Journal of Psychiatry · doi:10.1192/bjp.160.5.601 · Cited by 555 · see citing works
Hogarty, G. E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810280056008 · Cited by 510 · see citing works
The Community Management of Schizophrenia
Tarrier, N., Barrowclough, C., Vaughn, C. E., Bamrah, J., Porceddu, K., Watts, S., & Freeman, H. L. (1988) · The British Journal of Psychiatry · doi:10.1192/bjp.153.4.532 · Cited by 465 · see citing works
Herz, M. I., & Melville, C. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.7.801 · Cited by 456 · see citing works
Neuroleptic Withdrawal in Schizophrenic Patients
Gilbert, P. L. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950150005001 · Cited by 434 · see citing works
Skinner, H. A., Steinhauer, P. D., & Santa-Barbara, J. (1983) · Canadian Journal of Community Mental Health · doi:10.7870/cjcmh-1983-0018 · Cited by 430 · see citing works
Expressed emotion in families : its significance for mental illness
Leff, J., & Vaughn, C. E. (1985) · Medical Entomology and Zoology · Cited by 408 · see citing works
Research update on the psychosocial treatment of schizophrenia
Penn, D. L., & Mueser, K. T. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.5.607 · Cited by 406 · see citing works
Family Interventions for Schizophrenia
Dixon, L. B., & Lehman, A. F. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.631 · Cited by 394 · see citing works
Relapse and Rehospitalization During Maintenance Treatment of Schizophrenia
Schooler, N. R. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830170079011 · Cited by 298 · see citing works
Psychopharmacologic Treatment of Schizophrenia
Kane, J. M., & Marder, S. R. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.287 · Cited by 271 · see citing works
An overview of family interventions and relapse on schizophrenia: meta-analysis of research findings
Mari, J. D. J., & Streiner, D. L. (1994) · Psychological Medicine · doi:10.1017/s0033291700027720 · Cited by 265 · see citing works
Tarrier, N., Barrowclough, C., Vaughn, C. E., Bamrah, J., Porceddu, K., Watts, S., & Freeman, H. L. (1989) · The British Journal of Psychiatry · doi:10.1192/bjp.154.5.625 · Cited by 251 · see citing works
Psychosocial family intervention in schizophrenia: a review of empirical studies
Lam, D. H. (1991) · Psychological Medicine · doi:10.1017/s0033291700020535 · Cited by 249 · see citing works
Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment
Viguera, A. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130055011 · Cited by 246 · cited 1× · see citing works
“The speed at which medication should be reduced is still unknown, although from the review study of Viguera et al. (1997) it seems that patients discontinuing treatment gradually (> 3 weeks) have a lower risk of relapse than those being withdrawn from oral neuroleptic therapy abruptly.”
BackgroundLow- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome.
Marder, S. R., van Putten, T., Mintz, J., Lebell, M., Mckenzie, J., & May, P. R. A. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800180028005 · Cited by 226 · see citing works
Hogarty, G., Mcevoy, J., Munetz, M., DiBarry, A. L., Bartone, P., Cather, R., Cooley, S., Ulrich, R., Carter, M., & Madonia, M. J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330021002 · Cited by 218 · see citing works
Intermittent vs Maintenance Medication in Schizophrenia
Herz, M. I. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810280049007 · Cited by 205 · see citing works
Costs and Benefits of Two Doses of Fluphenazine
Marder, S. R. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790220015002 · Cited by 182 · see citing works
Jolley, A., Hirsch, S. R., Morrison, E., McRink, A., & Wilson, A. (1990) · BMJ · doi:10.1136/bmj.301.6756.837 · Cited by 171 · see citing works
Herz, M. I., Szymanski, H. V., & Simon, J. C. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.7.918 · Cited by 168 · see citing works
Early Intervention, Time-limited, Targeted Pharmacotherapy of Schizophrenia
Carpenter, W. T., & Heinrichs, D. W. (1983) · Schizophrenia Bulletin · doi:10.1093/schbul/9.4.533 · Cited by 139 · see citing works
An abbreviated form of the Phillips Rating Scale of Premorbid Adjustment in Schizophrenia.
Harris, J. G. (1975) · Journal of Abnormal Psychology · doi:10.1037/h0076983 · Cited by 132 · see citing works
Cook, T. D., Cooper, H. M., Cordray, D. S., Hartmann, H. I., Hedges, L. V., & Light, R. J. (1994) · Cited by 123 · see citing works
A unified approach to rank tests for mixed models
Akritas, M. G., & Brunner, E. (1997) · Journal of Statistical Planning and Inference · doi:10.1016/s0378-3758(96)00177-2 · Cited by 121 · see citing works
Behavioural Family Management in Schizophrenia
Randolph, E. T., Eth, S., Glynn, S. M., Paz, G. G., Leong, G. B., Shaner, A. L., STRACHAN, A. M., Vort, W. B. V., Escobar, J. I., & Liberman, R. P. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.4.501 · Cited by 120 · see citing works
Johnson, D. A. W., Ludlow, J. M., Street, K., & Taylor, R. D. W. (1987) · The British Journal of Psychiatry · doi:10.1192/bjp.151.5.634 · Cited by 108 · see citing works
A comparative trial of pharmacologic strategies in schizophrenia
Carpenter, W. T., Heinrichs, D. W., & Hanlon, T. E. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.11.1466 · Cited by 105 · see citing works
Vaughan, K., Doyle, M. L., McConaghy, N., Blaszczynski, A. P., Fox, A. M., & Tarrier, N. (1992) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00788951 · Cited by 102 · see citing works
Maintenance Medication for Schizophrenia: Strategies for Dose Reduction
Schooler, N. R. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.311 · Cited by 102 · see citing works
Early Neuroleptic Intervention in Schizophrenia: Are Prodromal Symptoms Valid Predictors of Relapse?
Gäebel, W., Frick, U., Köpcke, W., Linden, M., Müller, P., Müller-Spahn, F., Pietzcker, A., & Tegeler, J. (1993) · The British Journal of Psychiatry · doi:10.1192/s0007125000292416 · Cited by 100 · see citing works
Kh, N., Snyder, K. S., Me, D., Rappe, S. M., Gitlin, M. J., & Fogelson, D. L. (1986) · PubMed · Cited by 97 · see citing works
Pietźcker, A., Gäebel, W., Köpcke, W., Linden, M., Müller, P., Müller-Spahn, F., & Tegeler, J. (1993) · Journal of Psychiatric Research · doi:10.1016/0022-3956(93)90059-b · Cited by 83 · see citing works
Depot neuroleptics: the relevance of psychosocial factors--a United States perspective.
Sandler, A. P., THOMPSON, J. E., & Putney, D. (1984) · PubMed · Cited by 80 · see citing works
Depot neuroleptics: a comparative review of standard, intermediate, and low-dose regimens.
Kane, J. M., Woerner, M. G., & Sarantakos, S. (1986) · PubMed · Cited by 62 · see citing works
The use of the Panic and Agoraphobia Scale in a clinical trial
Bandelow, B., Brunner, E., Broocks, A., Beinroth, D., Hajak, G., Pralle, L., & Rüther, E. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(97)00118-2 · Cited by 59 · see citing works
Risks of Withdrawing Antipsychotic Medications
Wyatt, R. J. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950150037007 · Cited by 38 · see citing works
Ge, H., & Anderson, C. M. (1986) · PubMed · Cited by 32 · see citing works
Principles and results of family therapy in schizophrenia
Hahlweg, K., & Wiedemann, G. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/pl00014179 · Cited by 31 · see citing works
Self-citationMüller, P., Bandelow, B., Gäebel, W., Köpcke, W., Linden, M., Müller-Spahn, F., Pietźcker, A., Schaefer, E., & Tegeler, J. (1992) · The British Journal of Psychiatry · doi:10.1192/s0007125000297171 · Cited by 26 · see citing works
The future of neuroleptic psychopharmacology.
Ortiz, A., & Gershon, S. (1986) · PubMed · Cited by 23 · see citing works
Why Neuroleptic Withdrawal in Schizophrenia?
Carpenter, W. T. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950150024003 · Cited by 17 · see citing works
Family Interventions in the Community Management of Schizophrenia: Methods and Results
Falloon, I. R. H., Hahlweg, K., & Tarrier, N. (1990) · Springer eBooks · doi:10.1007/978-3-642-74308-5_11 · Cited by 17 · see citing works
Self-citationProcess Analysis in Behavioral Family Therapy
Hahlweg, K., Hemmati-Weber, M., Heusser, A., Lober, H., Winkler, H., Müller, U., Feinstein, E., & Dose, M. (1990) · Behavior Modification · doi:10.1177/01454455900144004 · Cited by 11 · see citing works
Self-citationRieg, C., Müller, U., Hahlweg, K., Wiedemann, G., Hank, G., & Feinstein, E. (2009) · Verhaltenstherapie · doi:10.1159/000257999 · Cited by 10 · see citing works
Self-citation
Flagged first, then by citations
1 of the 58 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Family Interventions for Schizophrenia and the Psychoses: A Review
McFarlane, W. R. (2016) · Family Process · doi:10.1111/famp.12235 · Cited by 293 · see citing works
Maintenance treatment with antipsychotic drugs for schizophrenia
Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., & Davis, J. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008016.pub2 · Cited by 287 · see citing works
Maintenance treatment with antipsychotic drugs for schizophrenia
Ceraso, A., Lin, J., Schneider‐Thoma, J., Siafis, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Davis, J. M., & Leucht, S. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008016.pub3 · Cited by 176 · see citing works
Chien, W. T., Leung, S. F., Yeung, F. K. K., & Wong, W. K. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s49263 · Cited by 149 · see citing works
Axis I disorders and personality disorders as risk factors for suicide
Schneider, B., Wetterling, T., Sargk, D., Schneider, F. W., Schnabel, A., Maurer, K., & Fritze, J. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0593-7 · Cited by 100 · see citing works
Binder, M. D., Sermon, J., Geerts, P., Vansteelandt, K., Peuskens, J., & Detraux, J. (2015) · CNS Drugs · doi:10.1007/s40263-015-0269-4 · Cited by 78 · see citing works
Assessing early signs of relapse in psychosis: Review and future directions
Eisner, E., Drake, R., & Barrowclough, C. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2013.04.001 · Cited by 75 · see citing works
Intermittent drug techniques for schizophrenia
Sampson, S. J., Mansour, M., Maayan, N., Soares‐Weiser, K., & Adams, C. E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006196.pub2 · Cited by 60 · see citing works
Educational needs of families caring for Chinese patients with schizophrenia
Chien, W. T., & Norman, I. J. (2003) · Journal of Advanced Nursing · doi:10.1046/j.0309-2402.2003.02832.x · Cited by 51 · see citing works
Caregiving processes and expressed emotion in psychosis, a cross-cultural, meta-analytic review
O’Driscoll, C., Sener, S. B., Angmark, A., & Shaikh, M. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.03.020 · Cited by 51 · see citing works
Clinical factors related to schizophrenia relapse
Porcelli, S., Bianchini, O., de Girolamo, G., Aguglia, E., Crea, L., & Serretti, A. (2016) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2016.1149195 · Cited by 47 · see citing works
Gumley, A. I., Bradstreet, S., Ainsworth, J. D., Allan, S., Álvarez‐Jiménez, M., Birchwood, M. J., Briggs, A. H., Bucci, S., Cotton, S., Engel, L., et al. (2022) · Health Technology Assessment · doi:10.3310/hlze0479 · Cited by 37 · see citing works
Family therapy for persons with schizophrenia: neglected yet important
Hahlweg, K., & Baucom, D. H. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01393-w · Cited by 27 · see citing works
Self-citationSchlier, B., Buck, L., Müller, R., Lincoln, T. M., Bott, A., & Pillny, M. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102291 · Cited by 14 · see citing works
Roldán, G. M., Salazar, I. C., Garrido, L., & Cuevas, A. M. (2015) · Anales de Psicologia · doi:10.6018/analesps.31.3.154071 · Cited by 9 · see citing works
Intervenciones familiares en la esquizofrenia. Cambios en la sintomatología y el ajuste social
Espina, A., & González, P. (2003) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 7 · see citing works
Maintenance therapy in schizophrenia: a critical comment
Chan, S. S. M., & Ungvari, G. S. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002961 · Cited by 6 · see citing works
Issues for further refinement of family interventions in schizophrenia.
Wiedemann, G. (2003) · PubMed · Cited by 5 · see citing works
Self-citationFamily interventions for serious mental illness: translating research to practice.
Lopez, S. R. (2003) · PubMed · Cited by 2 · see citing works
Wiedemann, G. (2004) · Steinkopff eBooks · doi:10.1007/978-3-7985-1957-2_51
Self-citationPradas, F. B. (2005) · TDX (Tesis Doctorals en Xarxa)
Current Awareness in human psychopharmacology
(2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.278
ผลของการบรบาลทางเภสชกรรมตอผลลพธทางคลนก และผลลพธแบบองครวมในผปวยจตเภท
พลไพรินทร์, ว., ศรีบุญเรือง, ท., พัฒนาฤดี, ส., & ศิลปกิจ, อ. (2021) · doi:10.58837/chula.the.2021.489
- Authors
- Wiedemann, G., Hahlweg, K., Müller, U., Feinstein, E., Hank, G., & Dose, M.
- Affiliations
- University of Tübingen (DE)
- Technische Universität Braunschweig (DE)
- Max Planck Institute of Psychiatry (DE)
- Venue
- European Archives of Psychiatry and Clinical Neuroscience
- Published
- 2001-05-18
- Volume
- 251
- Issue
- 2
- Pages
- 72-84
- ISSN
- 0003-9373 (ISSN-L)
- 0940-1334
- 1433-8491
- OpenAlex
- W2011803972
- Cited by
- 23
- References
- 58
- Citations by year
- 2023: 1 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 1 · 2016: 2 · 2015: 2 · 2013: 3 · 2012: 1
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Archives of Psychiatry and Clinical Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Family Caregiving in Mental Illness
- Social Sciences › Psychology › Clinical Psychology › Counseling, Therapy, and Family Dynamics
- Keywords
- schizophrenia, maintenance pharmacotherapy, family intervention, relapse, family burden, expressed emotion, social adaptation, psychopathology, antipsychotic adverse effects, treatment discontinuation
- MeSH terms
- Adolescent, Adult, Family Therapy, Female, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Schizophrenia, Schizophrenic Psychology, Antipsychotic Agents, Treatment Outcome, Expressed Emotion, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review